Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in June 2021 in Shanghai, China, Brise Pharma is a clinical-stage biopharmaceutical firm specializing in the creation of innovative and distinct therapeutic options for severe pain disorders. Our primary emphasis lies in developing treatments for conditions such as migraine, inflammatory pain, and neuropathic pain. Brise Pharma was initially established by a team of seasoned professionals boasting an average of over 15...
Founded in June 2021 in Shanghai, China, Brise Pharma is a clinical-stage biopharmaceutical firm specializing in the creation of innovative and distinct therapeutic options for severe pain disorders. Our primary emphasis lies in developing treatments for conditions such as migraine, inflammatory pain, and neuropathic pain. Brise Pharma was initially established by a team of seasoned professionals boasting an average of over 15 years of extensive experience in drug research and development on a global scale.

List your booth number for exhibitions, ask us